Lexicon Pharmaceuticals LXRX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's cash ratio?
- Lexicon Pharmaceuticals (LXRX) reported cash ratio of 6.8× in Q1 2026.
- How has Lexicon Pharmaceuticals's cash ratio changed year-over-year?
- Lexicon Pharmaceuticals's cash ratio increased by 1093.1% year-over-year, from 0.6× to 6.8×.
- What is the long-term trend for Lexicon Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's cash ratio has grown at a 2.4% compound annual growth rate (CAGR), from 2.7× to 3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.